Viropro acquires Biologics Process Development from Intas Biopharmaceuticals - MarketLine Financial Deals

Viropro acquires Biologics Process Development from Intas Biopharmaceuticals

Viropro acquires Biologics Process Development from Intas Biopharmaceuticals - MarketLine Financial Deals
Viropro acquires Biologics Process Development from Intas Biopharmaceuticals
Published Apr 14, 2010
3 pages — Published Apr 14, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Viropro, Inc., a Canada-based company engaged in the cell line and biopharmaceutical process development, has acquired Biologics Process Development, Inc., a US-based contract research organization (CRO), from Intas Biopharmaceuticals Limited (IBPL), an India-based biopharmaceutical company.

  
Source:
Document ID
MA16521_100107
Country
Country
Country
Ticker
VPRO=CA
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Viropro acquires Biologics Process Development from Intas Biopharmaceuticals" Apr 14, 2010. Alacra Store. Dec 07, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Viropro-acquires-Biologics-Process-Development-from-Intas-Biopharmaceuticals-2052-21155>
  
APA:
MarketLine Financial Deals. (2010). Viropro acquires Biologics Process Development from Intas Biopharmaceuticals Apr 14, 2010. New York, NY: Alacra Store. Retrieved Dec 07, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Viropro-acquires-Biologics-Process-Development-from-Intas-Biopharmaceuticals-2052-21155>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.